Hu, Z.; Zeng, H.; Hou, J.; Wang, J.; Xu, L.; Zhang, Y.; Chen, M.; Zhou, Z.
Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation. Viruses 2022, 14, 656.
https://doi.org/10.3390/v14040656
AMA Style
Hu Z, Zeng H, Hou J, Wang J, Xu L, Zhang Y, Chen M, Zhou Z.
Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation. Viruses. 2022; 14(4):656.
https://doi.org/10.3390/v14040656
Chicago/Turabian Style
Hu, Zili, Huilan Zeng, Jingyu Hou, Juncheng Wang, Li Xu, Yaojun Zhang, Minshan Chen, and Zhongguo Zhou.
2022. "Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation" Viruses 14, no. 4: 656.
https://doi.org/10.3390/v14040656
APA Style
Hu, Z., Zeng, H., Hou, J., Wang, J., Xu, L., Zhang, Y., Chen, M., & Zhou, Z.
(2022). Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation. Viruses, 14(4), 656.
https://doi.org/10.3390/v14040656